PLAYA VISTA, Calif., Oct. 10, 2018 — American Premium Water Corporation (OTC Pink: HIPH) (the “Company”) announces that SeeThruEquity has revised upwards its initial price target for the Company from $0.15 to a revised target price of $0.30, with the report adding, “intriguing speculative growth company, targeting large consumer opportunities… with the launch of LALPINA Hydro CBD and its subsequent ecommerce distribution announcements with SingleSeed.com and DIGSHydro.com, subsidiaries of SinglePoint, Inc, as well as strategic deals expanding the company’s presence in the luxury consumer markets.”
Ryan Fishoff, American Premium Water CEO, commented, “Having American Premium’s price target revised upward by SeeThruEquity is a validation of management’s current plan. Over the past year, HIPH has transformed, entered one of the fastest growing sectors of the American economy (CBD), significantly reduced debt levels, made strategic acquisitions, entered into substantial distribution agreements, and, most importantly, positioned itself for substantial growth. The Company welcomes SeeThruEquity’s continued research coverage and looks forward to supplying its analysts with more developments as we continue achieving our business plan targets in the near future.”
SeeThruEquity analysts have placed a price target on HIPH common shares at $0.30, which represents a potential upside of 471.4% from the recent price of $0.0525 on Oct. 9, 2018. In the report, the firm further outlines expectations for the Company, as the launch of its CBD beverage enables HIPH to enter the large and rapidly growing CBD market, which, in the U.S., generated sales of $820 million in 2017 and is projected to grow at a compounded rate of 54% to reach $3 billion by 2020, according to Greenware Advisors. The firm also highlights potential growth on the pharma side, as HIPH is optimistic it will benefit from the recent DEA action removing CBD as Schedule 1 drug when there is 0.1% or less trace amounts of THC. Such products will now be classified as Schedule 5 drugs, as long as the medications have been approved by the FDA. While LALPINA Hydro CBD is not FDA-approved, it contains non-detectable amounts of THC, and HIPH may now be in a position to explore partnerships for medical applications of a formulation of its product. The full report can be viewed at http://www.seethruequity.com.
“Management and the Company share SeeThru’s belief that the CBD market presents a tremendous growth opportunity. As I’ve said before, I believe HIPH has the combination of a unique product like LALPINA Hydro CBD, which is the only hydro-nano CBD product on the market, and the proven ability to successfully market a beverage brand that will separate the Company from others in the short and long term.”
American Premium Water Corp. is the public holding trading company that owns LALPINA HYDRO, LALPINA HYDRO CBD, Gents, Worthy and FashionCoinX.
Safe Harbor Notice Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company’s business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (“SEC”) EDGAR database.
This press release is issued on behalf of the Board of Directors of American Premium Water Corporation
Ryan Fishoff email: [email protected] +1(888) 983-0054